Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after mRNA COVID-19 Vaccination.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 33904778.
- Also identified by DOI 10.1148/radiol.2021210886 and PMC identifier 8082565.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Ipsilateral avid axillary lymph node uptake at FDG PET/CT persists in 29% (49 of 169) of patients between 7 to 10 weeks after the second dose of the mRNA-based BNT162b2 COVID-19 vaccination.
Medical subject headings
- COVID-19
- Fluorodeoxyglucose F18